# Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection

> **NCT06018363** · PHASE1,PHASE2 · RECRUITING · sponsor: **Dushu Lake Hospital Affiliated to Soochow University** · enrollment: 25 (estimated)

## Conditions studied

- Brain Gliomas
- High-Grade Gliomas
- GBM

## Interventions

- **BIOLOGICAL:** Allogenic B7-H3 CAR-γδT cell(QH104)

## Key facts

- **NCT ID:** NCT06018363
- **Lead sponsor:** Dushu Lake Hospital Affiliated to Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06018363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06018363, "Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06018363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*